Changing prescription drug sector: New expenditure methodologies

Health Care Financing Review

Volumn 17, Issue 3, 1996, Pages 191-204

  Genuardi, James S ^a   Stiller, Jean M ^b   Trapnell, Gordon R ^a  

^a Actuarial Research Corporation   (United States)

^b HFCA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG COST; DRUG INDUSTRY; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; PRESCRIPTION; REIMBURSEMENT; DRUG MARKETING;

DRUG INDUSTRY; FINANCING, PERSONAL; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; INSURANCE, HEALTH, REIMBURSEMENT; INSURANCE, PHARMACEUTICAL SERVICES; MANAGED CARE PROGRAMS; MEDICAID; PRESCRIPTIONS, DRUG; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0030008331     PISSN: 01958631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cohen, L., and Tanouye, E.: Drug Makers Set to Pay $600 Million to Settle Lawsuit by Pharmacies, Wall Street Journal P. 1, January 18, 1996.
2. Congressional Budget Office: How the Medicaid Rebate on Prescription Drugs Affects Pricing in the Pharmaceutical Industry. Washington, DC. January 1996.
3. Congressional Budget Office: How Health Care Reform Affects Pharmaceutical Research and Development. Washington, DC. June 1994.
4. Day, K.: A Bitter Pill to Swallow, Small Pharmacies Struggling as Profit Margins Shrink. The Washington Post P. 1, Washington Business Section, February 26, 1996.
5. Health Care Financing Administration: Calculations performed by the Office of the Actuary based on Medicaid drug rebate information file from the Medicaid Bureau, unpublished. 1995.
6. IMS America:-National Prescription Audit. Plymouth Meeting, PA. August 21, 1995.
7. IMS America: U.S. Hospital Audit. Plymouth Meeting, PA. 1994
8. Levit, K.R., Sensenig, A.L., Cowan, CA., et al.: National Health Expenditures, 1994. Health Care Financing Review 17(3): Spring 1996.
9. National Association of Retail Druggists - Lilly Digest Survey of 1993 Operational Data Pp. 23-24. Alexandria, VA, 1994.
10. Muirhead, G.: The ABC's of PBMs, Drug Topics (5 September 1994): 67-79.
11. Comptroller General of the United States: Pharmacy Benefit Managers: Early Results on Ventures With Drug Manufacturers. Washington, DC. U.S. Government Accounting Office, November 1995.
12. Pharmaceutical Research and Manufacturers of America: Annual Survey 1988-90. Pharmaceutical Manufactures Association Report P. 9. Washington, D.C. 1990.
13. SMG Marketing Group, Inc.: HMO Data. Chicago, IL, 1993.
14. Trapnell, G.R. and Genuardi, J.S.: Consumer Expenditures for Prescription Drugs, 1971-1985, Annandale, VA: Actuarial Research Corporation, February 1987.
15. Trapnell, G.R., and Genuardi, J.S.: National Health Accounts Drug Study. Contract Number 500-94-0004. Prepared for the Health Care Financing Administration. Annandale, VA. 1994.
16. U.S. Bureau of Labor Statistics: Consumer Price Index. U.S. Department of Labor. Washington, U.S. Government Printing Office, 1960-90.
17. U.S. Department of Commerce: Personal Consumption Expenditures. Bureau of Economic Analysis. Washington. U.S. Government Printing Office, 1996.
18. U.S. Department of Commerce: Merchandise Line Sales. Bureau of the Census. Washington, U.S. Government Printing Office, 1992.